Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression

Journal of Cellular Physiology
Qi ChenBin Xu

Abstract

Chloride channel-3 (ClC-3), a member of the ClC family of voltage-gated Cl- channels, is involved in the resistance of tumor cells to chemotherapeutic drugs. Here, we report a new mechanism for ClC-3 in mediating multidrug resistance (MDR). ClC-3 was highly expressed in the P-glycoprotein (P-gp)-dependent human lung adenocarcinoma cell line (A549)/paclitaxel (PTX) and the human breast carcinoma cell line (MCF-7)/doxorubicin (DOX) resistant cells. Changes in the ClC-3 expression resulted in the development of drug resistance in formerly drug-sensitive A549 or MCF-7 cells, and drug sensitivity in formerly drug-resistant A549/Taxol and MCF-7/DOX cells. Double transgenic MMTV-PyMT/CLCN3 mice with spontaneous mammary cancer and ClC-3 overexpression demonstrated drug resistance to PTX and DOX. ClC-3 expression upregulated the expression of MDR1 messenger RNA and P-gp by activating the nuclear factor-κB (NF-κB)-signaling pathway. These data suggest that ClC-3 expression in cancer cells induces MDR by upregulating NF-κB-signaling-dependent P-gp expression involving another new mechanism for ClC-3 in the development of drug resistance of cancers.

References

Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J E RosM Müller
Sep 25, 2001·Toxicological Sciences : an Official Journal of the Society of Toxicology·Q HuangK T Blanchard
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Katrina L MealeyDeborah T Kochevar
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
May 9, 2002·American Journal of Physiology. Cell Physiology·Xinhua LiSteven A Weinman
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Mar 1, 1964·Journal of Pharmaceutical Sciences·S M KUPCHANP W WANEVENHOVEN
Oct 27, 2004·The Journal of Biological Chemistry·Mariko Hara-ChikumaA S Verkman
Feb 22, 2005·British Journal of Pharmacology·Yan-Ping DaiIlia A Yamboliev
Mar 17, 2007·Molecular Cancer Therapeutics·Karsten H WeylandtAlessandro Sardini
Oct 28, 2008·Current Biology : CB·Jennifer MitchellStephen B Shears
May 4, 2011·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Ye XuLian-Kun Sun
Mar 1, 2012·Histochemistry and Cell Biology·Jianwen MaoLixin Chen
Nov 21, 2012·The Journal of Physiology·Laurel M FarmerDeborah J Nelson
Feb 15, 2013·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Jing SuLian-Kun Sun
Mar 8, 2013·Hearing Research·Sofia Waissbluth, Sam J Daniel
Nov 26, 2014·Oncology Reports·Sen HongChunyan Zhao
Mar 10, 2015·F1000prime Reports·Stephan Wilkens
Aug 31, 2017·European Journal of Medicinal Chemistry·Giovanni Luca BerettaLaura Gatti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.